Hepatitis C and steatosis

Seminars in Gastrointestinal Disease

Volumn 13, Issue 1, 2002, Pages 40-46

  Monto, Alex ^a  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FATTY LIVER; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FIBROSIS; LIVER TRANSPLANTATION; MALE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; RISK FACTOR; SYMPTOM; VIRUS GENE;

ANIMALS; ANTIVIRAL AGENTS; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FATTY LIVER; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; LIVER TRANSPLANTATION; MITOCHONDRIA, LIVER; OXIDATION-REDUCTION; RISK FACTORS;

EID: 0036207473     PISSN: 10495118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Natural history of liver fibrosis in patients with chronic hepatitis C
2. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: A french survey of 6,664 patients
3. Prognosis of chronic hepatitis C: Results of a large, prospective cohort study
4. Hepatitis C virus infection following liver transplantation
5. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis
6. The pathology of hepatitis C
7. Isolation of cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
8. Histopathology of hepatitis C virus infection
9. Nonalcoholic steatohepatitis: Definition and pathology
10. Epidemiology of alcoholic liver disease
11. Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C
12. Host- and disease-specific factors affecting streatosis in chronic hepatitis C
13. Hepatic steatosis in chronic hepatitis C virus infection: Prevalence and clinical correlation
14. Steatosis and bile duct damage in chronic hepatitis C: Distribution and relationships in a group of Northern Italian patients
15. Steatosis on liver biopsy in patients with hepatitis C is associated with obesity and diabetes, but not with lifetime alcohol use
16. Hepatocyte steatosis is a cytopathic effect of hepatitis C genotype 3
17. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity
18. Hepatitis C virus induced hypobetalipoproteinemia: A possible mechanism for steatosis in chronic hepatitis C
19. Expression of hepatitis C virus envelope proteins in transgenic mice
20. Hepatitis C core protein induces hepatic steatosis in transgenic mice
21. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
22. A transgenic mouse model of steatosis and hepatocellular carcinoma associated with chronic hepatitis C infection in humans
23. Hepatocellular carcinoma
24. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis
25. Hepatitis C virus core protein shows a cytoplasmic localization and associates to intracellular lipid storage droplets
26. Oxidative damage in circulating leukocytes occurs as an early event in chronic hepatitis C infection
27. In situ detection of lipid peroxidation in chronic hepatitis C: Correlation with pathological features
28. Mitochondria in steatohepatitis
29. Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: Ultrastructural and biochemical findings
30. Diabetes mellitus and chronic hepatitis C virus infection
31. Association of diabetes mellitus and chronic hepatitis C infection
32. HCV and diabetes mellitus: Evidence for a negative association
33. Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection
34. Chronic hepatitis C and superimposed nonalcoholic fatty liver disease
35. In vivo effects of interferon-alpha and interferon-gamma on lipolysis and ketogenesis
36. Interferon alpha induces disorder of lipid metabolism by lowering postheparin lipases and cholesterol ester transfer protein activities in patients with chronic hepatitis C
37. Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases
38. Hepatic steatosis: A specific sign of hepatitis C reinfection after liver transplantation
39. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease
40. Prediction of liver allograft fibrosis after liver transplantation for hepatitis C virus: Persistent elevation of serum transaminase levels versus necroinflammatory activity
41. HCV-related fibrosis progression following liver transplantation: Increase in recent years
42. Antiretroviral-induced hepatic steatosis and lactic acidosis: Case report and review of the literature
43. Influence of human immunodeficiency virus type I infection on the natural course of chronic parenterally, acquired hepatitis C
44. Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: A comparison between immunocompetent and immunocompromised patients
45. A pilot study of thiazolidinedione, Troglitazone, in nonalcoholic steatohepatitis